Pilot Study [resa]
Simvastatin [orch, phsu]
ciprofibrate [orch, phsu]
Combination [qlco]
Myocardial Infarction [dsyn]
Profile [lbpr]
Patients [podg]
Refractory [ftcn]
familial [famg]
Combined hyperlipidemia NOS [dsyn]
Profile [lbpr]
Myocardial Infarction [dsyn]
Efficacy [qlco]
Combined therapy [topp]
Simvastatin [orch, phsu]
ciprofibrate [orch, phsu]
Patients [podg]
Refractory [ftcn]
Familial combined hyperlipidaemia [dsyn]
investigated [ftcn]
Patients [podg]
Males [fndg]
Females [fndg]
Age [orga]
Range [qnco]
coronary heart disease [dsyn]
baseline [bodm]
Study [mnob]
Patients [podg]
Diet [food]
Plus [qlco]
placebo [topp]
Fur [imft]
Beginning [tmco]
Patients [podg]
Received [qlco]
combined treatment [topp]
Simvastatin 20 MG [clnd]
ciprofibrate 100 MG [clnd]
months [tmco]
months [tmco]
plasma concentration [qnco]
Following [tmco]
Parameters [fndg]
Measured [qlco]
Total Cholesterol [lbpr]
Low Density Lipoprotein Cholesterol [bacs, strd]
LDLC [gngm]
Very low density lipoprotein cholesterol [bacs, strd]
High Density Lipoprotein Cholesterol [bacs, lipd]
Triglycerides [bacs, lipd]
Apoproteins B [aapp, bacs]
Fibrinogen [aapp, bacs, phsu]
combined treatment [topp]
Probability [qnco]
Myocardial Infarction [dsyn]
Calculated [ftcn]
Sixth [qnco]
Combined therapy [topp]
Calculated [ftcn]
Myocardial Infarction [dsyn]
Reduced [qlco]
Following [tmco]
Modification [ftcn]
Compared [acty]
placebo [topp]
Record [inpr]
Total Cholesterol [lbpr]
LDLC [gngm]
High Density Lipoprotein Cholesterol [bacs, lipd]
Triglycerides [bacs, lipd]
apo B-32 [aapp]
LDC [gngm]
High Density Lipoprotein Cholesterol [bacs, lipd]
Ratio [qnco]
Apo-B [aapp, bacs]
Ratio [qnco]
Plasma [bdsu]
Fibrinogen [aapp, bacs, phsu]
P NOS [aapp, imft]
Withdrawn [fndg]
Study [mnob]
Sustained [ftcn]
Transaminase [aapp, enzy]
Values [qlco]
Myopathy [dsyn]
adverse effects [ftcn]
drug combination [phsu]
Record [inpr]
conclude [bodm, orch]
combined treatment [topp]
Simvastatin [orch, phsu]
ciprofibrate [orch, phsu]
Efficient [qlco]
Myocardial Infarction [dsyn]
Profile [lbpr]
Patients [podg]
Familial combined hyperlipidaemia [dsyn]
Administered [ftcn]
Select [acty]
Patients [podg]
Severe [qlco]
Combined hyperlipidemia NOS [dsyn]
Close [ftcn]
Monitoring [hlca]
Patients [podg]
adverse effects [ftcn]
drug combination [phsu]
